BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 28
• 29
• 30
• 31

• Drug Development

  European Medicines Agency Ordered Not to Release AbbVie’s Trial Data, for Now

  May 1, 2013

   · 

  1 min read
• Business

  StemCell Technologies Inc. Obtains License From iPS Academia Japan, Inc. for Induced Pluripotent Stem Cell Technologies

  May 1, 2013

   · 

  3 min read
• Policy

  FDA Delays Approval of Titan Pharmaceuticals’s Suboxone Implant

  May 1, 2013

   · 

  5 min read
• FDA

  Raptor Pharmaceutical Inc. Receives FDA Approval for Procysbi

  May 1, 2013

   · 

  8 min read
• Drug Development

  OncoGenex Pharmaceuticals Inc. Announces Plans for the Initiation of the Rainier™ Clinical Trial Evaluating OGX-427 in Combination With ABRAXANE® Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

  May 1, 2013

   · 

  5 min read
• Drug Development

  Omeros Corporation Requests Fast Track Designation for OMS824 for the Treatment of Huntington’s Disease

  May 1, 2013

   · 

  4 min read
• Drug Development

  Clinical Results for Oramed Pharmaceuticals Inc.'s Oral Diabetes Treatment Published in Peer Reviewed Journal PLOS ONE

  May 1, 2013

   · 

  2 min read
• BioMidwest

  Hospira, Inc. Unveils Global Device Strategy

  May 1, 2013

   · 

  4 min read
• Alimera Sciences Announces New PDUFA Date for ILUVIEN®

  May 1, 2013

   · 

  6 min read
• Martindale Pharma® Launches Tapclob®, the First Licensed Oral Liquid Suspension of Clobazam

  May 1, 2013

   · 

  2 min read